Chandan Healthcare IPO subscribed 7.04 times overall on the last day, a retail quota was subscribed over 2.44 times, NII was subscribed over 18.85 times, QIB was subscribed over 7.58.
Chandan Healthcare IPO details
Chandan Healthcare got approval from SEBI for an IPO of ₹107.36 crores. This IPO comprises a fresh issue of ₹70.79 crores and offer-for-sale up to 22,99,936 equity shares with a face value of Rs 10 each. Further, it had a set price band between ₹151 to ₹159 per share.
In this IPO 800 shares were in 1 lot size for retail minimum and maximum category.
Moreover, 1600 shares were in 2 lot sizes for the S-HNI category.
To invest in Chandan Healthcare IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum and maximum investment of ₹1,27,200
- SHNI (S-HNI): Minimum investment of ₹2,54,400.
Chandan Healthcare IPO’s Subscription Duration
Chandan Healthcare IPO’s subscription started on February 10, 2025, and closed on February 12, 2025.
The Chandan Healthcare IPO’s allotment date was February 13, 2025, and they received a refund on February 14, 2025. Chandan Healthcare IPO listing is on February 17, 2025.
Chandan Healthcare Funds Deployment
- The raised funds will be used for building up a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh.
- Establishing a new Central Reference laboratory at Ayodhya, Uttar Pradesh
- Utilized the funds to build a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh.
- Lastly, the remaining funds will be used for the company’s General corporate purposes.
About Chandan Healthcare Company
Founded in September 2003, Chandan Healthcare Company is one of the growing companies renowned in providing testing services such as pathology and radiology testing services. Across India, the company has one flagship laboratory, seven central laboratories, twenty-six satellite centres, more than three hundred collection centres as of August 31, 2024. Moreover, it is spread in more than 15 cities and towns in Uttar Pradesh and over 10 cities and towns in Uttarakhand. There range of tests include 169 routine pathology tests, covering basic biochemistry and hematology, as well as 713 specialized pathology tests, such as immunohistopathology, and molecular pathology, and 236 radiology tests, including basic x-rays, ultrasonography (“USG”), computed tomography (“CT”), magnetic resonance imaging (“MRI”), and specialized CT scans. Chandan Healthcare has been growing continuously with an experienced team of 14 radiologists, 25 pathologists, and more than 161 qualified professionals including clinicians, technicians and operators as of August 31, 2024.
Chandan Healthcare IPO Company Financial Report
The company reported revenue of ₹177.96 crores in 2024 against ₹137.03 crore in 2023. The company reported profit of ₹16.36 crores in 2024 against profit of ₹3.59 crores in 2023.
